Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 03-Apr-24 5:43 PM View:  | Recursion Pharmaceuticals, ... (RXRX) | 01-Apr-24 | Grant | 1,267 | -- | -- | < 1% 3.17M to 3.17M | |
| 12-Feb-24 4:03 PM View: | Schering-Plough Corp. (MRK) | 09-Feb-24 | Option Exercise | 14,702 | $62.07 | $912,553.00 | 32% 46.24K to 60.94K | |
| 12-Feb-24 4:03 PM View: | Schering-Plough Corp. (MRK) | 09-Feb-24 | Option Sale | 14,702 | $125.50 | $1,845,080.00 | (24%) 60.94K to 46.24K | |
| 24-Jan-24 4:10 PM View: | Schering-Plough Corp. (MRK) | 22-Jan-24 | Grant | 25,760 | $119.43 | $3,076,520.00 | 126% 20.48K to 46.24K | |
| 11-Jan-24 6:51 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 09-Jan-24 | Market Sale (Planned) | 29,000 | $13.66 | $396,214.00 | (< 1%) 3.2M to 3.17M | (13%) |
| 04-Jan-24 6:11 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 02-Jan-24 | Grant | 1,203 | -- | -- | < 1% 3.2M to 3.2M | |
| 04-Oct-23 5:46 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 02-Oct-23 | Grant | 1,659 | -- | -- | < 1% 3.2M to 3.2M | |
| 06-Jul-23 6:10 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jul-23 | Grant | 1,609 | -- | -- | < 1% 3.82M to 3.82M | |
| 21-Jun-23 5:23 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Jun-23 | Grant | 12,612 | -- | -- | < 1% 3.81M to 3.82M | |
| 03-May-23 4:10 PM View: | Schering-Plough Corp. (MRK) | 01-May-23 | Payment of Exercise | 524 | $115.47 | $60,506.30 | (2%) 21.0K to 20.47K | |
| 03-May-23 4:10 PM View: | Schering-Plough Corp. (MRK) | 01-May-23 | Option Exercise | 1,062 | $115.47 | $122,629.00 | 5% 19.93K to 21.0K | |
| 04-Oct-23 5:46 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 21-Apr-23 | Gift | 627,705 | -- | -- | (16%) 3.82M to 3.2M | |
| 05-Apr-23 6:00 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Apr-23 | Grant | 1,724 | -- | -- | < 1% 3.81M to 3.81M | |
| 25-Jan-23 4:59 PM View: | Schering-Plough Corp. (MRK) | 23-Jan-23 | Grant | 3,275 | $109.88 | $359,857.00 | 20% 16.66K to 19.93K | |
| 05-Jan-23 6:29 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jan-23 | Grant | 1,573 | -- | -- | < 1% 3.81M to 3.81M | |
| 05-Oct-22 9:15 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Oct-22 | Grant | 1,092 | -- | -- | < 1% 3.81M to 3.81M | |
| 06-Jul-22 5:51 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Jul-22 | Grant | 1,409 | -- | -- | < 1% 3.8M to 3.81M | |
| 16-Jun-22 8:18 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 14-Jun-22 | Grant | 18,145 | -- | -- | < 1% 3.79M to 3.8M | |
| 04-May-22 5:50 PM View: | Schering-Plough Corp. (MRK) | 03-May-22 | Payment of Exercise | 381 | $87.65 | $33,394.70 | (2%) 16.84K to 16.46K | |
| 04-May-22 5:50 PM View: | Schering-Plough Corp. (MRK) | 03-May-22 | Option Exercise | 773 | $87.65 | $67,753.50 | 5% 16.07K to 16.84K | (6%) |
| 03-May-22 4:21 PM View: | Schering-Plough Corp. (MRK) | 01-May-22 | Payment of Exercise | 523 | $88.69 | $46,384.90 | (3%) 16.59K to 16.07K | |
| 03-May-22 4:21 PM View: | Schering-Plough Corp. (MRK) | 01-May-22 | Option Exercise | 1,061 | $88.69 | $94,100.10 | 7% 15.53K to 16.59K | (7%) |
| 05-Apr-22 7:21 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Apr-22 | Grant | 1,544 | -- | -- | < 1% 3.78M to 3.79M | |
| 28-Feb-22 10:00 PM View: | Schering-Plough Corp. (MRK) | 24-Feb-22 | Grant | 3,023 | $73.51 | $222,221.00 | 24% 12.44K to 15.46K | |
| 05-Jan-22 8:46 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 03-Jan-22 | Grant | 659 | -- | -- | < 1% 3.78M to 3.78M | |
| 09-Dec-21 9:21 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 07-Dec-21 | Market Sale (Planned) | 15,900 | $20.48 | $325,630.00 | (< 1%) 3.8M to 3.78M | 3% |
| 19-Nov-21 5:40 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 19-Nov-21 | Market Sale (Planned) | 13,474 | $20.20 | $272,226.00 | (< 1%) 3.81M to 3.8M | 5% |
| 19-Nov-21 5:40 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 17-Nov-21 | Market Sale (Planned) | 5,626 | $20.04 | $112,736.00 | (< 1%) 3.82M to 3.81M | 4% |
| 05-Oct-21 8:24 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Oct-21 | Grant | 543 | -- | -- | < 1% 3.82M to 3.82M | |
| 06-Jul-21 5:00 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 01-Jul-21 | Grant | 330 | -- | -- | < 1% 3.82M to 3.82M | |
| 06-May-21 4:55 PM View: | Schering-Plough Corp. (MRK) | 04-May-21 | Payment of Exercise | 238 | $75.98 | $18,083.20 | (2%) 12.55K to 12.31K | (2%) |
| 06-May-21 4:55 PM View: | Schering-Plough Corp. (MRK) | 04-May-21 | Option Exercise | 694 | $75.98 | $52,730.10 | 6% 11.85K to 12.55K | 2% |
| 04-May-21 4:57 PM View: | Schering-Plough Corp. (MRK) | 03-May-21 | Payment of Exercise | 257 | $74.50 | $19,146.50 | (2%) 12.11K to 11.85K | (2%) |
| 04-May-21 4:57 PM View: | Schering-Plough Corp. (MRK) | 03-May-21 | Option Exercise | 750 | $74.50 | $55,875.00 | 7% 11.36K to 12.11K | 2% |
| 04-May-21 4:57 PM View: | Schering-Plough Corp. (MRK) | 01-May-21 | Payment of Exercise | 354 | $74.50 | $26,373.00 | (3%) 11.71K to 11.36K | (2%) |
| 04-May-21 4:57 PM View: | Schering-Plough Corp. (MRK) | 01-May-21 | Option Exercise | 1,030 | $74.50 | $76,735.00 | 10% 10.69K to 11.71K | 2% |
| 22-Apr-21 8:06 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 20-Apr-21 | Conversion Duplicate | 55,383 | -- | -- | 1% 3.76M to 3.82M | |
| 22-Apr-21 8:06 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 20-Apr-21 | Acquisition (other) | 3,222,050 | -- | -- | 84% 3.82M to 7.04M | |
| 22-Apr-21 8:06 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 20-Apr-21 | Acquisition (other) | 596,390 | -- | -- | 8% 7.04M to 7.64M | |
| 22-Apr-21 8:06 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 20-Apr-21 | Disposition (other) | 3,222,050 | -- | -- | (42%) 7.64M to 4.41M | |
| 22-Apr-21 8:06 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 20-Apr-21 | Disposition (other) | 596,390 | -- | -- | (14%) 4.41M to 3.82M | |
| 19-Apr-21 7:28 PM View: | Recursion Pharmaceuticals, ... (RXRX) | 16-Apr-21 | Grant | 13,889 | -- | -- | < 1% 3.75M to 3.76M | |
| 02-Mar-21 12:00 PM View: | Schering-Plough Corp. (MRK) | 26-Feb-21 | Grant | 3,485 | $72.62 | $253,081.00 | 49% 7.17K to 10.65K | (< 1%) |